Shanghai Kehua Bio-engineering Co (SZSE:002022) Total Liabilities : ¥1,736 Mil (As of Mar. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Shanghai Kehua Bio-engineering Co Total Liabilities?

Shanghai Kehua Bio-engineering Co's Total Liabilities for the quarter that ended in Mar. 2024 was ¥1,736 Mil.

Shanghai Kehua Bio-engineering Co's quarterly Total Liabilities increased from Sep. 2023 (¥1,813.25 Mil) to Dec. 2023 (¥1,823.52 Mil) but then declined from Dec. 2023 (¥1,823.52 Mil) to Mar. 2024 (¥1,736.14 Mil).

Shanghai Kehua Bio-engineering Co's annual Total Liabilities increased from Dec. 2021 (¥1,823.95 Mil) to Dec. 2022 (¥2,966.59 Mil) but then declined from Dec. 2022 (¥2,966.59 Mil) to Dec. 2023 (¥1,823.52 Mil).

Shanghai Kehua Bio-engineering Co Total Liabilities Historical Data

The historical data trend for Shanghai Kehua Bio-engineering Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Kehua Bio-engineering Co Total Liabilities Chart

Shanghai Kehua Bio-engineering Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

1,014.34

2,108.82

1,823.95

2,966.59

1,823.52

Shanghai Kehua Bio-engineering Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															2,287.39	2,011.91	1,813.25	1,823.52	1,736.14

Shanghai Kehua Bio-engineering Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Shanghai Kehua Bio-engineering Co's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	902.918	+	(801.957	+	118.641
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	1,824

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	6807.74	-	4984.224
	=	1,824

Shanghai Kehua Bio-engineering Co's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	817.399	+	(801.418	+	117.319
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	1,736

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	6620.133	-	4883.998
	=	1,736

Shanghai Kehua Bio-engineering Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Shanghai Kehua Bio-engineering Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Kehua Bio-engineering Co (SZSE:002022) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai Kehua Bio-engineering Co Ltd (SZSE:002022) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1189 Qinzhou North Road, Xuhui District, Shanghai, CHN, 200233

Website

http://www.skhb.com

Shanghai Kehua Bio-engineering Co Ltd is a developer, manufacturer, and marketer of in-vitro diagnostics business in China. Its products are mainly offered in two primary business segments: Diagnostic Reagents and Diagnostic Laboratory Instruments. Its products include diagnostic reagents, such as enzyme-immunoassay kits, clinical chemistry reagents, PCR kits, and rapid test kits and lab-instruments comprising chemistry analyzers, microplate washers/readers, electrolyte analyzers, and nucleic acid extractors.

Executives

Li Ming	Executives
He Jian Wen	Executives
Ji Yu Ming	Supervisors
Li Ji	Executives
Sha Li Wu	Director
Wang Man	Directors, executives
Tang Wei Guo	Director

Shanghai Kehua Bio-engineering Co (SZSE:002022) Headlines

No Headlines